SCHEMBL7576571

SCHEMBL7576571

N#Cc1c(N)cc(C(F)(F)F)cc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.41
GAA P10253 9/20 0.41
KDM4E B2RXH2 9/20 0.41
HPGD P15428 8/20 0.41
GLA P06280 7/20 0.41
TP53 P04637 1/20 0.41
AR P10275 2/20 0.39
PTPN5 P54829 2/20 0.38
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570304 0.86 ALDH1A1 (0.47) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL25983118 0.78 AR (0.47) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL27414564 0.75 ALDH1A1 (0.46) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL3118151 0.75 ALDH1A1 (0.46) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL23301575 0.73 AR (0.46) AR
SCHEMBL24155176 0.73 KDM4E (0.38) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL27764178 0.73 PTPN5 (0.44) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL205002 0.73 ALDH1A1 (0.50) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL27082431 0.71 PTPN5 (0.42) ALDH1A1GAAKDM4EHPGDGLA
SCHEMBL2370038 0.71 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDARPTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362372-B2 HYDROGENATION OF A TRIFLUOROBENZYLNITRILE BY HYDROGEN IN AN ORGANIC SOLVENT IN THE PRESENCE OF AMMONIA AND A CATALYST COMPRISING A PLATINUM GROUP ELEMENT; EXTREMELY HIGH YIELDS CENTRAL GLASS COMPANY, LIMITED (JP) 2002-03-26 US disclosed
US-20020007086-A1 Process for producing trifluoromethylbenzylamines CENTRAL GLASS COMPANY, LIMITED (JP) 2002-01-17 US disclosed
US-6175041-B1 HYDROGENATING A TRIFLUOROMETHYLBENZONITRILE WITH HYDROGEN IN AN ORGANIC SOLVENT IN THE PRESENCE OF AMMONIA, USING A RANEY CATALYST CENTRAL GLASS COMPANY, LIMITED (JP) 2001-01-16 US disclosed
US-5188641-A Acrylic polymers for dyeing textiles, plastics, paints, paper and lacquers; colorfastness; intensity IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007086-A1 Process for producing trifluoromethylbenzylamines IDH1, INMT, TH ALDH1A1 1093/4885GAA 3355/4885KDM4E 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.